So based on Tuesday's conference call is sounds like there will be 3 sales forces - BMS, AZ & Legacy when the realignments are completed after Q1. Where does that leave Synergy? They talked about BMS wants bigger not smaller. I don't buy it. Forxiga won't be on the market until sometime in 2014 so they won't hold on to us to wait for a launch. There are already too many of us selling Bydureon and Onglyza. Can't even leave a sample in an office!!!!
Any way you slice it, I think we are all toast April 1st.
Thoughts?
Good Luck!!!